&Partners’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$809K Buy
8,952
+1,593
+22% +$135K ﹤0.01% 1545
2026
Q1
$615K Sell
7,359
-2,119
-22% -$174K ﹤0.01% 1583
2025
Q4
$852K Buy
9,478
+3,163
+50% +$303K ﹤0.01% 1311
2025
Q3
$598K Sell
6,315
-246
-4% -$23.2K ﹤0.01% 1353
2025
Q2
$687K Buy
6,561
+2,808
+75% +$266K 0.01% 1176
2025
Q1
$327K Buy
+3,753
New +$385K ﹤0.01% 1362

Other funds holding HQY

&Partners's HQY Position: Q2 2026 in Review

&Partners increased its HealthEquity (HQY) stake by 22% in Q2 2026, buying an estimated $135K and bringing the position to 8,952 shares worth $809K. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

&Partners first reported a position in HQY in Q1 2025 and has held it in 6 quarters since. The position peaked at $852K in Q4 2025. 501 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • &Partners held 8,952 shares of HealthEquity worth $809K as of Q2 2026.
  • &Partners bought 1,593 HealthEquity shares in Q2 2026, an estimated $135K.
  • HealthEquity made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1545 holding.
  • &Partners first reported a position in HealthEquity in Q1 2025 and has held it in 6 quarters since.
  • &Partners's HealthEquity position peaked at $852K in Q4 2025.
  • 501 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.